Search

Your search keyword '"Swart, Karin M. A."' showing total 208 results

Search Constraints

Start Over You searched for: Author "Swart, Karin M. A." Remove constraint Author: "Swart, Karin M. A."
208 results on '"Swart, Karin M. A."'

Search Results

2. A meta-analysis of previous falls and subsequent fracture risk in cohort studies

3. Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands

4. Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study

7. Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe

9. Protein-coding variants implicate novel genes related to lipid homeostasis contributing to body-fat distribution

10. Safety and effectiveness of rivaroxaban for prevention of stroke in patients with nonvalvular atrial fibrillation: analysis of routine clinical data from four countries

11. Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study

12. Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study

13. Vitamin D deficiency in Europe: pandemic?

15. Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries

16. Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate:An Interrupted Time Series Study

18. A Randomized Controlled Trial to Examine the Effect of 2-Year Vitamin B12 and Folic Acid Supplementation on Physical Performance, Strength, and Falling: Additional Findings from the B-PROOF Study

19. The Association Between the Kyphosis Angle and Physical Performance in Community-Dwelling Older Adults

20. Myocarditis and pericarditis associated with SARS-CoV-2 vaccines: A population-based descriptive cohort and a nested self-controlled risk interval study using electronic health care data from four European countries

22. Effect of Vitamin B12 and Folic Acid Supplementation on Bone Mineral Density and Quantitative Ultrasound Parameters in Older People with an Elevated Plasma Homocysteine Level: B-PROOF, a Randomized Controlled Trial

23. Large meta-analysis of genome-wide association studies identifies five loci for lean body mass

24. Development and validation of an algorithm to estimate the risk of severe complications of COVID-19: a retrospective cohort study in primary care in the Netherlands

25. Associations Between Medication Use and Homocysteine Levels in an Older Population, and Potential Mediation by Vitamin B12 and Folate: Data from the B-PROOF Study

26. Effectiveness of COVID-19 Vaccines in Adults with Diabetes Mellitus: A Systematic Review.

28. Predicting hospital admissions from individual patient data (IPD): an applied example to explore key elements driving external validity

29. Non-linear associations between serum 25-OH vitamin D and indices of arterial stiffness and arteriosclerosis in an older population

30. Medication-Related Fall Incidents in an Older, Ambulant Population: The B-PROOF Study

32. Predicting hospital admissions from individual patient data (IPD): an applied example to explore key elements driving external validity

33. Discovery of predictors of sudden cardiac arrest in diabetes: rationale and outline of the RESCUED (REcognition of Sudden Cardiac arrest vUlnErability in Diabetes) project

34. Disentangling the genetics of lean mass

35. Disentangling the genetics of lean mass

36. Effect of Genetically Low 25-Hydroxyvitamin D on Mortality Risk: Mendelian Randomization Analysis in 3 Large European Cohorts

38. Erratum:Large meta-analysis of genome-wide association studies identifies five loci for lean body mass (Nature Communications (2017) 8:80 DOI: 10.1038/s41467-017-00031-7)

39. Beta-blocker use and fall risk in older individuals:Original results from two studies with meta-analysis

41. Erratum: Large meta-analysis of genome-wide association studies identifies five loci for lean body mass

42. Erratum : Large meta-analysis of genome-wide association studies identifies five loci for lean body mass.

43. Folate and vitamin B12-related biomarkers in relation to brain volumes

44. Folate and vitamin B12-related biomarkers in relation to brain volumes

45. Large meta-analysis of genome-wide association studies identifies five loci for lean body mass

46. Vitamin D and mortality: Individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium

47. Folic Acid and Vitamin B12 Supplementation and the Risk of Cancer: Long-term Follow-up of the B Vitamins for the Prevention of Osteoporotic Fractures (B-PROOF) Trial.

48. New loci for body fat percentage reveal link between adiposity and cardiometabolic disease risk

50. New loci for body fat percentage reveal link between adiposity and cardiometabolic disease risk

Catalog

Books, media, physical & digital resources